Home › Osteosarcoma › Oklahoma
Osteosarcoma clinical trials in Oklahoma
3 studies for Osteosarcoma are looking for participants at sites in Oklahoma.
Cities in Oklahoma
Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
- University Of Oklahoma Health Sciences Center, Oklahoma City
RecruitingPhase 1
12 Months – 20 Years · All sexes · Updated Oct 8, 2026 · NCT02013336Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
- University of Oklahoma Health Sciences Center, Oklahoma City
RecruitingPhase 3
Up to age 50 · All sexes · Updated Aug 25, 2026 · NCT05235165Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- University of Oklahoma Health Sciences Center, Oklahoma City
RecruitingObservational study
All ages · All sexes · Updated May 18, 2026 · NCT01790152From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.